Hervé Hoppenot joined Incyte in 2014 as President and CEO and was later appointed Chairman of the Board of Directors in 2015. Under his leadership, Incyte has grown tremendously, tripling its clinical candidates and expanding its research into new therapeutic areas focusing on rare and often hard-to-treat diseases. Incyte also expanded geographically with clinical development and commercial presence in North America, Europe and Asia.

“I am honored to be receiving the Pete du Pont Freedom Award on behalf of Incyte. Our mission to Solve On. is driven by our relentless pursuit to find answers for patients by following the science. This award reaffirms our commitment to pioneering progress and recognizes the collective experience, passion and perseverance of our entire team.” – Hervé Hoppenot, President and CEO, Incyte